SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
Clinical trials for SQUAMOUS CELL CARCINOMA OF HEAD AND NECK explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA OF HEAD AND NECK trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA OF HEAD AND NECK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug enters first human tests for multiple advanced tumors
Disease control TerminatedThis early-phase study aimed to test the safety, side effects, and best dose of an experimental drug called QEQ278 in adults with advanced solid tumors. It enrolled 30 participants with specific advanced cancers (lung, kidney, esophageal, or head/neck) that had progressed despite…
Matched conditions: SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 23:11 UTC
-
Radiation planning aims to save space for future teeth
Disease control TerminatedThis study tested whether planning for future dental implants before starting radiation treatment could help protect healthy jawbone areas. Researchers used special scans to mark potential implant sites, then designed radiation plans to avoid damaging those areas while still trea…
Matched conditions: SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
Phase: NA • Sponsor: Institut de cancérologie Strasbourg Europe • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Terminated trial tests new weapon against tough head & neck cancers
Disease control TerminatedThis study aimed to see if adding an experimental drug called magrolimab to standard cancer treatments could help control advanced head and neck cancer that had returned or spread. It was designed for adults whose cancer had progressed despite prior therapy. The trial was termina…
Matched conditions: SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Experimental combo aims to boost immune attack on tough head & neck cancers
Disease control TerminatedThis study tested whether adding an experimental drug called SAR444245 to standard cancer treatments could help people with advanced head and neck cancer. It involved 59 adults whose cancer had returned or spread. The goal was to see if the combination led to more tumor shrinkage…
Matched conditions: SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New cancer drug trial halted after early testing
Disease control TerminatedThis early-stage study tested a new drug called OC-001, both by itself and combined with an existing immunotherapy drug, in people with various advanced cancers that had stopped responding to standard treatments. The main goal was to check the safety of the drug and see how the b…
Matched conditions: SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
Phase: PHASE1, PHASE2 • Sponsor: Ocellaris Pharma, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC